Physiomics Plc (AIM:PYC)
London · Delayed Price · Currency is GBP · Price in GBX 0.2939
+0.0039 (1.34%)
Dec 5, 2025, 12:40 PM GMT+1
Physiomics Revenue
In the fiscal year ending June 30, 2025, Physiomics had annual revenue of 834.16K GBP with 46.20% growth. Physiomics had revenue of 480.16K in the half year ending June 30, 2025, with 84.86% growth.
Revenue
834.16K
Revenue Growth
+46.20%
P/S Ratio
1.05
Revenue / Employee
83.42K
Employees
10
Market Cap
879.31K
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 834.16K | 263.60K | 46.20% |
| Jun 30, 2024 | 570.56K | -35.17K | -5.81% |
| Jun 30, 2023 | 605.73K | -294.97K | -32.75% |
| Jun 30, 2022 | 900.71K | 169.81K | 23.23% |
| Jun 30, 2021 | 730.90K | -110.75K | -13.16% |
| Jun 30, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Jun 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.24B |
| GSK plc | 32.17B |
| Haleon | 11.02B |
| Smith & Nephew | 4.33B |
| Hikma Pharmaceuticals | 2.35B |
| Convatec Group | 1.72B |
| Spire Healthcare Group | 1.55B |
| Genus | 672.80M |
Physiomics News
- 2 months ago - Full Year 2025 Physiomics PLC Investor Presentation Transcript - GuruFocus
- 10 months ago - AIM Market Roundup: Future Metals, Eurasia Mining, Blackbird - The Armchair Trader